|
JPS56110674A
(en)
|
1980-01-24 |
1981-09-01 |
Janssen Pharmaceutica Nv |
Novel 11*cyclohexyl**44aryll44piperidine carboxylic acid derivative
|
|
US4369184A
(en)
|
1980-01-24 |
1983-01-18 |
Janssen Pharmaceutica N.V. |
1-(Cyclohexyl)-4-aryl-4-piperidinecarboxylic acid derivatives
|
|
US5852029A
(en)
|
1990-04-10 |
1998-12-22 |
Israel Institute For Biological Research |
Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity
|
|
GB9300194D0
(en)
|
1993-01-06 |
1993-03-03 |
Wyeth John & Brother Ltd |
Piperazine derivatives
|
|
US5446051A
(en)
|
1994-05-31 |
1995-08-29 |
Eli Lilly And Company |
Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
|
|
CA2200468A1
(en)
|
1994-10-27 |
1996-05-09 |
Wayne J. Thompson |
Muscarine antagonists
|
|
IL117149A0
(en)
*
|
1995-02-23 |
1996-06-18 |
Schering Corp |
Muscarinic antagonists
|
|
US5889006A
(en)
*
|
1995-02-23 |
1999-03-30 |
Schering Corporation |
Muscarinic antagonists
|
|
AU7478496A
(en)
|
1995-10-31 |
1997-05-22 |
Merck & Co., Inc. |
Muscarine antagonists
|
|
US5854245A
(en)
|
1996-06-28 |
1998-12-29 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
ATE311377T1
(de)
|
1996-08-26 |
2005-12-15 |
Pfizer |
Spirocyclische dopaminrezeptor-subtyp-liganden
|
|
AU734892B2
(en)
|
1997-06-18 |
2001-06-28 |
Merck & Co., Inc. |
Alpha 1a adrenergic receptor antagonists
|
|
GB9715892D0
(en)
|
1997-07-29 |
1997-10-01 |
Zeneca Ltd |
Heterocyclic compounds
|
|
WO1999032489A1
(en)
|
1997-12-23 |
1999-07-01 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
|
AU2095099A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Phthalimide-piperidine, -pyrrolidine and -azepine derivatives, their preparationand their use as muscarinic receptor (ant-)agonists
|
|
AU2307999A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
|
AU2307899A
(en)
|
1997-12-23 |
1999-07-12 |
Alcon Laboratories, Inc. |
Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
|
|
CZ286152B6
(cs)
|
1998-03-13 |
2000-01-12 |
Miroslav Ing. Csc. Vlček |
Transparentní a semitransparentní difrakční prvky
|
|
EP1076055B1
(en)
|
1998-04-28 |
2004-11-24 |
Dainippon Pharmaceutical Co., Ltd. |
1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
|
|
US6387930B1
(en)
|
1999-05-04 |
2002-05-14 |
Schering Corporation |
Piperidine derivatives useful as CCR5 antagonists
|
|
HK1039330B
(en)
*
|
1999-05-04 |
2005-12-09 |
Schering Corporation |
Piperidine derivatives useful as ccr5 antagonists
|
|
ES2238277T3
(es)
|
1999-05-04 |
2005-09-01 |
Schering Corporation |
Terapia anti-vih con una combinacion de un interferon alfa-pegilado y un antagonista de ccr5.
|
|
ES2199856T3
(es)
|
1999-09-13 |
2004-03-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Nuevos compuestos heterociclicos, utiles como inhibidores reversibles de cisteina proteasas.
|
|
US6420364B1
(en)
|
1999-09-13 |
2002-07-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compound useful as reversible inhibitors of cysteine proteases
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
US6699880B1
(en)
|
1999-10-13 |
2004-03-02 |
Banyu Pharmaceutical Co., Ltd. |
Substituted imidazolidinone derivatives
|
|
WO2002064567A2
(en)
|
2000-11-28 |
2002-08-22 |
Eli Lilly And Company |
Substituted carboxamides as inhibitors of factor xa
|
|
EP1386920A4
(en)
|
2001-04-20 |
2005-09-14 |
Banyu Pharma Co Ltd |
benzimidazolone derivatives
|
|
WO2002100399A1
(en)
*
|
2001-06-12 |
2002-12-19 |
Elan Pharmaceuticals, Inc. |
Macrocycles useful in the treatment of alzheimer's disease
|
|
WO2004089942A2
(en)
|
2001-10-02 |
2004-10-21 |
Acadia Pharmaceuticals Inc. |
Benzimidazolidinone derivatives as muscarinic agents
|
|
GB0128378D0
(en)
|
2001-11-27 |
2002-01-16 |
Smithkline Beecham Plc |
Novel Compounds
|
|
IL162616A0
(en)
|
2001-12-28 |
2005-11-20 |
Acadia Pharm Inc |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
US7550459B2
(en)
|
2001-12-28 |
2009-06-23 |
Acadia Pharmaceuticals, Inc. |
Tetrahydroquinoline analogues as muscarinic agonists
|
|
US7256186B2
(en)
|
2002-02-06 |
2007-08-14 |
Schering Corporation |
Gamma secretase inhibitors
|
|
US20040171614A1
(en)
|
2002-02-06 |
2004-09-02 |
Schering-Plough Corporation |
Novel gamma secretase inhibitors
|
|
ES2336905T3
(es)
|
2002-03-28 |
2010-04-19 |
Mitsubishi Tanabe Pharma Corporation |
Derivado de benzofurano.
|
|
US7524852B2
(en)
|
2002-06-07 |
2009-04-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Bicyclic pyrimidine derivatives
|
|
US7265147B2
(en)
|
2002-07-31 |
2007-09-04 |
Ranbaxy Laboratories Limited |
3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
|
|
KR20050062575A
(ko)
|
2002-09-30 |
2005-06-23 |
뉴로서치 에이/에스 |
신규한 1,4-디아자바이사이클로알칸 유도체, 이의 제법 및용도
|
|
CN1753897A
(zh)
|
2002-11-22 |
2006-03-29 |
日本烟草产业株式会社 |
稠合双环含氮杂环
|
|
AU2003293129B2
(en)
|
2002-11-27 |
2009-03-12 |
Incyte Holdings Corporation |
3-aminopyrrolidine derivatives as modulators of chemokine receptors
|
|
WO2004069828A1
(ja)
|
2003-02-04 |
2004-08-19 |
Mitsubishi Pharma Corporation |
ピペリジン化合物およびその医薬用途
|
|
EP1647553A4
(en)
|
2003-07-17 |
2008-12-31 |
Astellas Pharma Inc |
2-ACYLAMINOTHIAZOL DERIVATIVE OR SALT THEREOF
|
|
EP1679069A4
(en)
|
2003-10-21 |
2009-05-13 |
Dainippon Sumitomo Pharma Co |
NEW PIPERIDINE DERIVATIVE
|
|
ATE428422T1
(de)
|
2004-02-05 |
2009-05-15 |
Schering Corp |
Piperidin-derivate als ccr3-antagonisten
|
|
CA2554671A1
(en)
|
2004-02-10 |
2005-08-18 |
F.Hoffmann-La Roche Ag |
Chemokine ccr5 receptor modulators
|
|
US7488745B2
(en)
|
2004-07-16 |
2009-02-10 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7504424B2
(en)
|
2004-07-16 |
2009-03-17 |
Schering Corporation |
Compounds for the treatment of inflammatory disorders
|
|
US7786141B2
(en)
|
2004-08-19 |
2010-08-31 |
Vertex Pharmaceuticals Incorporated |
Dihydrospiroindene modulators of muscarinic receptors
|
|
JP2008521821A
(ja)
*
|
2004-11-29 |
2008-06-26 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ムスカリン受容体のモジュレーター
|
|
JP4774995B2
(ja)
|
2005-01-12 |
2011-09-21 |
アステラス製薬株式会社 |
アシルアミノチアゾール誘導体を有効成分とする医薬組成物
|
|
WO2006105035A2
(en)
|
2005-03-28 |
2006-10-05 |
Vertex Pharmaceuticals Incorporated |
Muscarinic modulators
|
|
EP1900732A4
(en)
|
2005-06-24 |
2009-11-18 |
Toyama Chemical Co Ltd |
NEW NITROGENATED HETEROCYCLIC COMPOUND AND SALT THEREOF
|
|
AU2006330866A1
(en)
|
2005-12-22 |
2007-07-05 |
Vertex Pharmaceuticals Incorporated |
Modulators of muscarinic receptors
|
|
TW201307354A
(zh)
|
2005-12-29 |
2013-02-16 |
Abbott Lab |
蛋白質激酶抑制劑
|
|
RU2008137583A
(ru)
|
2006-02-22 |
2010-03-27 |
Вертекс Фармасьютикалз Инкорпорейшн (Us) |
Спиропиперидины в качестве модуляторов мускариновых рецепторов
|
|
CN101426499A
(zh)
|
2006-02-22 |
2009-05-06 |
弗特克斯药品有限公司 |
毒蕈碱受体调节剂
|
|
WO2008021375A2
(en)
|
2006-08-15 |
2008-02-21 |
Vertex Pharmaceuticals Incorporated |
Modulators of muscarinic receptors
|
|
CN101610761A
(zh)
|
2006-12-22 |
2009-12-23 |
诺瓦提斯公司 |
作为ddp-iv抑制剂的1-氨基甲基-l-苯基-环己烷衍生物
|
|
WO2008117229A1
(en)
|
2007-03-23 |
2008-10-02 |
Ranbaxy Laboratories Limited |
Muscarinic receptor antagonists
|
|
US8119661B2
(en)
|
2007-09-11 |
2012-02-21 |
Astrazeneca Ab |
Piperidine derivatives and their use as muscarinic receptor modulators
|
|
UY31672A1
(es)
|
2008-02-28 |
2009-09-30 |
|
"agonistas de receptores muscarínicos composiciones farmacéuticas métodos de tratamiento de los mismos, y procedimientos para su preparación"
|
|
ES2395347T3
(es)
|
2008-03-27 |
2013-02-12 |
Janssen Pharmaceutica, N.V. |
Derivados de indolilalquilamino sustituidos con aza-biciclohexilo como inhibidores novedosos de histona desacetilasa
|
|
JP2012506883A
(ja)
|
2008-10-29 |
2012-03-22 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
置換されたスピロアミン
|
|
CN102256963B
(zh)
|
2008-12-19 |
2014-06-11 |
贝林格尔.英格海姆国际有限公司 |
作为ccr2受体拮抗剂用于治疗炎症、哮喘和copd的环状嘧啶-4-甲酰胺
|
|
CN102459227B
(zh)
|
2009-04-17 |
2014-08-20 |
詹森药业有限公司 |
Ccr2的4-氮杂环丁烷基-1-苯基-环己烷拮抗剂
|
|
FR2945531A1
(fr)
|
2009-05-12 |
2010-11-19 |
Sanofi Aventis |
Derives de 7-aza-spiro°3,5!nonane-7-carboxylates, leur preparation et leur application en therapeutique
|
|
US20130197027A1
(en)
|
2010-03-10 |
2013-08-01 |
Craig Lindsley |
Heterocyclyl-azabicyclo[3.2.1]octane analogs as selective m1 agonists and methods of making and using same
|
|
CN102939283B
(zh)
|
2010-04-22 |
2015-06-03 |
詹森药业有限公司 |
可用作己酮糖激酶抑制剂的吲唑化合物
|
|
US8921394B2
(en)
|
2010-04-27 |
2014-12-30 |
Merck Sharp & Dohme Corp. |
Prolylcarboxypeptidase inhibitors
|
|
EP2568812B1
(en)
|
2010-05-11 |
2016-10-26 |
Merck Sharp & Dohme Corp. |
Novel prolylcarboxypeptidase inhibitors
|
|
CN102918031A
(zh)
|
2010-05-28 |
2013-02-06 |
通用电气健康护理有限公司 |
放射标记的化合物及其方法
|
|
SG188985A1
(en)
|
2010-09-17 |
2013-05-31 |
Array Biopharma Inc |
Piperidinyl-substituted lactams as gpr119 modulators
|
|
US20140005165A1
(en)
|
2011-03-17 |
2014-01-02 |
Anilkumar G. Nair |
Substituted 3-azabicyclo[3.1.0]hexane derivatives useful as ccr2 antagonists
|
|
JP2013010719A
(ja)
|
2011-06-30 |
2013-01-17 |
Dainippon Sumitomo Pharma Co Ltd |
ベンズイミダゾロンおよびオキシインドール誘導体ならびにそれらの医薬用途
|
|
CN102354931B
(zh)
|
2011-10-12 |
2013-08-28 |
上海电瓷厂 |
一组多功能构件组成带电作业绝缘工具
|
|
US9187451B2
(en)
|
2011-11-18 |
2015-11-17 |
Heptares Therapeutics Limited |
Muscarinic M1 receptor agonists
|
|
AU2013299557B2
(en)
|
2012-08-10 |
2017-06-22 |
Boehringer Ingelheim International Gmbh |
Heteroaromatic compounds as Bruton's tyrosine kinase (BTK) inhibitors
|
|
ES2602039T3
(es)
*
|
2012-09-18 |
2017-02-17 |
Heptares Therapeutics Limited |
Compuestos aza bicíclicos como agonistas del receptor M1 muscarínico
|
|
ES2694299T3
(es)
*
|
2013-02-07 |
2018-12-19 |
Heptares Therapeutics Limited |
Carboxilatos de piperidin-1-ilo y azepin-1-ilo como agonistas del receptor muscarínico M4
|
|
JP6479029B2
(ja)
|
2014-02-06 |
2019-03-06 |
ヘプタレス セラピューティクス リミテッドHeptares Therapeutics Limited |
ムスカリンm1受容体アゴニストとしての二環式アザ化合物
|
|
GB201404922D0
(en)
|
2014-03-19 |
2014-04-30 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
SG11201706501VA
(en)
|
2015-02-13 |
2017-09-28 |
Suven Life Sciences Ltd |
AMIDE COMPOUNDS AS 5-HT<sb>4</sb> RECEPTOR AGONISTS
|
|
GB201504675D0
(en)
|
2015-03-19 |
2015-05-06 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201513740D0
(en)
|
2015-08-03 |
2015-09-16 |
Heptares Therapeutics Ltd |
Muscarinic agonist
|
|
GB201513742D0
(en)
|
2015-08-03 |
2015-09-16 |
Heptares Therapeutics Ltd |
Muscarinic agonists
|
|
GB201513743D0
(en)
|
2015-08-03 |
2015-09-16 |
Heptares Therapeutics Ltd |
Muscarinic agonists
|
|
GB201519352D0
(en)
|
2015-11-02 |
2015-12-16 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
US10259787B2
(en)
|
2016-10-14 |
2019-04-16 |
Heptares Therapeutics Limited |
Substituted cyclohexanes as muscarinic M1 receptor and/or M4 receptor agonists
|
|
GB201617454D0
(en)
|
2016-10-14 |
2016-11-30 |
Heptares Therapeutics Limited |
Pharmaceutical compounds
|
|
GB201709652D0
(en)
|
2017-06-16 |
2017-08-02 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
US10501483B2
(en)
|
2017-10-24 |
2019-12-10 |
Allergan, Inc. |
Enamines and diastereo-selective reduction of enamines
|
|
GB201810239D0
(en)
|
2018-06-22 |
2018-08-08 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201810245D0
(en)
|
2018-06-22 |
2018-08-08 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201819960D0
(en)
|
2018-12-07 |
2019-01-23 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB201819961D0
(en)
|
2018-12-07 |
2019-01-23 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB202020191D0
(en)
|
2020-12-18 |
2021-02-03 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds
|
|
GB202103211D0
(en)
|
2021-03-08 |
2021-04-21 |
Heptares Therapeutics Ltd |
Pharmaceutical compounds for use in therapy
|